SCI & TECH● LOWJul 17 · Jul 17, 2026, 6:45 AM
Telix Completes Patient Enrollment in TLX591 - Px ( Illuccix ) Japan Phase 3 Study
malaysiasun.com · Malaysia
Telix has completed patient enrollment for a Phase 3 study of its product TLX591-Px (Illuccix) in Japan. This marks a significant milestone in the product's clinical development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More from Malaysia
BUSINESS3h agoAmerican Resources forms Indo-Pacific unit to lead Malaysia rare earth expansionSeeking Alpha TechPOLITICS4h agoMalaysia’s Najib loses bid to suspend 15-year 1MDB sentence on medical groundsSouth China Morning PostBUSINESS8h agoYoung Malaysians’ US$1.3bn short-term credit spree sparks warning over bad debtSouth China Morning PostWORLD1d ago5 Malaysian nationals arrested for alleged smuggling of cocaine hidden in shoesJapan Today
More in Sci & Tech
SCI & TECH21m agoWorld’s oldest shipwreck off Turkey: 4,700-year-old amphorae discoveredEuroNews [en]SCI & TECH39m agoA fossil skull was hidden for 100 years in a drawer and now it is discovered to be a new species of dinosaurClarínSCI & TECH52m agoHesai launches 3D spatial camera as Chinese lidar maker expands into physical AISouth China Morning PostSCI & TECH1h agoRobot allegedly used to grope teen girl seized by German policeCBS News